A randomized controlled trial of HIV therapeutic vaccination using ALVAC with or without Remune
Investigating whether the use of ALVAC with Remune may induce anti-HIV responses capable of controlling viral replication
View PublicationInvestigating whether the use of ALVAC with Remune may induce anti-HIV responses capable of controlling viral replication
View PublicationDescribing unique design features and investigational procedures that were applied to a CTN 173 to enhance HIV immunity
View PublicationThe first study examining motivation to participate in an HIV therapeutic vaccine trial of Remune and ALVAC
View PublicationDescribing the design of a trial that evaluates whether antidepressant prophylaxis is superior to early detection and treatment of depression in increasing the successful completion of HCV therapy.
View PublicationAssessing whether adding valproic acid to stable HAART could potentially reduce the size of the latent viral reservoir in CD4 T cells of chronically infected patients
View PublicationComparing changes in noninvasive markers before and after sustained virologic response in HIV-HCV coinfected patients
View PublicationExamining the impact of spontaneous clearance of HCV on CD4+ T-lymphocyte count progression before and after initiation of ART in HIV–HCV coinfected adults
View PublicationEvaluating factors associated with discordance between the absolute CD4 cell count and the CD4 cell percentage in HIV/HCV-coinfected patients
View PublicationInvestigating morbidity and mortality in an HIV/HCV‐coinfected population in care
View Publication